Table 1.

Individual responses on the PSST, the PAF, and the QIDS

Participant	PSSTtotala	PSST core symptomsb	PSST other symptomsb	PSST PSST interferenceb	PAF1	paf2	paf3	PAF1–3 (SD)c	QIDS1	QIDS2	QIDS3	QIDS1–3 (SD)d
A	55	3	7	3	47	48	43	46 (2.6)	10	11	14	11.7 (2.1)
B	52	4	7	1	48	47	51	48.7 (2.1)	4	10	5	6.3 (3.2)
C	49	4	6	2	50	50	42	47.3 (4.6)	5	4	7	5.3 (1.5)
D	49	2	8	1	37	36	27	33.3 (5.5)	18	18	14	16.7 (2.3)
E	47	2	5	2	33	37	46	38.7 (6.7)	1	2	6	3 (2.6)
F	47	4	4	1	40	33	39	37.3 (3.8)	2	5	2	3 (1.7)
G	47	2	7	1	42	24	27	31 (9.6)	3	6	6	5 (1.7)
H	43	2	7	1	36	29	30	31.7 (3.8)	6	9	8	7.7 (1.5)
I	43	2	4	0	35	37	32	34.7 (2.5)	9	17	14	13.3 (4.0)
Mean of all	48.0	2.8	6.1	1.3	40.9	37.9	37.4	38.7	6.4	9.1	8.4	8.0
particpants (SD)	(3.9)	(0.97)	(1.5)	(0.87)	(6.2)	(8.9)	(8.8)	(6.9)	(5.3)	(5.6)	(4.5)	(4.8)

The PAF and the QIDS were administered: (1) before, (2) halfway, and (3) after the social interaction data collection. PSST, Premenstrual Symptoms Screening Tool; PAF, Premenstrual Assessment Form; QIDS, Quick Inventory of Depressive Symptomatology.

^aTotal score of all items combined.

^bNumber of items with a score indicating moderate-to-severe symptoms or interference.

^cValues are based on the mean of PAF₁, PAF₂, and PAF₃. ^d Values are based on the mean of QIDS₁, QIDS₂, and QIDS₃.